Menarini Asia-Pacific
Menarini is the world’s largest Italian biopharmaceutical company with a heritage of over 128 years, and more than 16,000 employees in over 100 countries. Here in Asia-Pacific, Menarini’s vision is to be a leading provider of important healthcare brands to improve the lives of people in the region.
See below for the Latest Menarini Asia-Pacific News, Analysis, Profit Results, Share Price Information, and Commentary.
How Menarini Asia Pacific achieves organisational excellence, harnesses agile go-to market approaches
CEO Maurizio Luongo highlights the expansion of the company’s omni-channel distribution strategy beyond traditional pharmaceuticals channels.
How Menarini Asia Pacific achieves organisational excellence, harnesses agile go-to market approaches
CEO Maurizio Luongo highlights the expansion of the company’s omni-channel distribution strategy beyond traditional pharmaceuticals channels.
Menarini Asia-Pacific bags two awards at the SBR Management Excellence Awards 2022
It was recognised for having a robust team and an outstanding leader that guided the company to success.
Commentary
Contract 'of' or 'for' Service? Or a New Legal Creature? The Singapore Platform Worker’s Bill